Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 23, 2024

SELL
$100.73 - $112.44 $589,774 - $658,336
-5,855 Reduced 33.63%
11,556 $1.2 Million
Q1 2024

Apr 15, 2024

BUY
$109.52 - $120.96 $164,170 - $181,319
1,499 Added 9.42%
17,411 $1.98 Million
Q4 2023

Feb 06, 2024

BUY
$90.19 - $110.4 $169,286 - $207,220
1,877 Added 13.37%
15,912 $1.75 Million
Q3 2023

Oct 23, 2023

BUY
$95.53 - $114.62 $393,679 - $472,349
4,121 Added 41.57%
14,035 $1.36 Million
Q2 2023

Jul 21, 2023

SELL
$100.78 - $112.29 $4,434 - $4,940
-44 Reduced 0.44%
9,914 $1.08 Million
Q1 2023

Apr 11, 2023

BUY
$96.86 - $114.01 $8,426 - $9,918
87 Added 0.88%
9,958 $1.01 Million
Q4 2022

Feb 15, 2023

BUY
$95.06 - $111.52 $938,337 - $1.1 Million
9,871 New
9,871 $1.08 Million
Q3 2022

Nov 08, 2022

SELL
$96.76 - $112.03 $5,515 - $6,385
-57 Reduced 0.58%
9,851 $953,000
Q2 2022

Aug 02, 2022

BUY
$102.07 - $123.37 $266,708 - $322,365
2,613 Added 35.82%
9,908 $1.08 Million
Q1 2022

May 13, 2022

BUY
$114.02 - $139.04 $495,530 - $604,267
4,346 Added 147.37%
7,295 $863,000
Q4 2021

Feb 02, 2022

SELL
$115.53 - $141.46 $308,580 - $377,839
-2,671 Reduced 47.53%
2,949 $415,000
Q3 2021

Oct 18, 2021

BUY
$116.66 - $129.06 $9,799 - $10,841
84 Added 1.52%
5,620 $664,000
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $154,664 - $182,062
-1,462 Reduced 20.89%
5,536 $642,000
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $280,480 - $330,448
2,577 Added 58.29%
6,998 $839,000
Q4 2020

Feb 26, 2021

BUY
$105.0 - $114.42 $34,650 - $37,758
330 Added 8.07%
4,421 $484,000
Q4 2020

Feb 09, 2021

SELL
$105.0 - $114.42 $420,000 - $457,680
-4,000 Reduced 49.44%
4,091 $484,000
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $352,630 - $428,243
3,848 Added 90.69%
8,091 $881,000
Q2 2020

Aug 19, 2020

SELL
$76.57 - $98.0 $11,715 - $14,994
-153 Reduced 3.48%
4,243 $388,000
Q4 2019

Mar 03, 2020

BUY
$78.51 - $87.4 $345,129 - $384,210
4,396 New
4,396 $382,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rmr Wealth Builders Portfolio

Follow Rmr Wealth Builders and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

News

Stay updated on Rmr Wealth Builders with notifications on news.